Literature DB >> 3933685

Effect of selective vaccination on rubella susceptibility and infection in pregnancy.

C L Miller, E Miller, P J Sequeira, J E Cradock-Watson, M Longson, E C Wiseberg.   

Abstract

The effect of school and adult vaccination on susceptibility to rubella in women of childbearing age was assessed in the Manchester area, where the population attending antenatal clinics is over 40 000 a year. Between 1979 and 1984 the proportion susceptible fell from 6.4% to 2.7%. In 1984, 4.2% of nulliparous women were susceptible compared with 1.4% of women in their second or subsequent pregnancy. Eighty five per cent of pregnant women screened and found to be non-immune were vaccinated post partum before leaving hospital. Requests for prevaccination screening of non-pregnant women increased in response to a national campaign and at the time of local outbreaks of rubella but only two thirds of those found to be nonimmune were subsequently vaccinated. During 1983 and 1984 infection was confirmed in 57 pregnant women--2% of those non-immune. Selective vaccination has reduced susceptibility to rubella in the childbearing population, but it is suggested that mass vaccination of children of both sexes should be added to the existing policy to control circulation of wild rubella virus and reduce the risk of infection to pregnant women who remain susceptible.

Entities:  

Mesh:

Year:  1985        PMID: 3933685      PMCID: PMC1419038          DOI: 10.1136/bmj.291.6506.1398

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  5 in total

1.  National Congenital Rubella Surveillance Programme 1 July 1971-30 June 1984.

Authors:  R W Smithells; S Sheppard; H Holzel; A Dickson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-06

2.  Implementation of the rubella vaccination programme in Manchester.

Authors:  A E Jones
Journal:  Community Med       Date:  1983-11

3.  Immunisation policies.

Authors:  J A Dudgeon
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-07

4.  Role of the occupational health service in screening and increasing the uptake of rubella immunisation.

Authors:  S J Jachuck; C L Bound; C E Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-12

5.  Rubella vaccination of schoolgirls: factors affecting vaccine uptake.

Authors:  C S Peckham; W C Marshall; J A Dudgeon
Journal:  Br Med J       Date:  1977-03-19
  5 in total
  15 in total

Review 1.  Rubella in Europe.

Authors:  A Galazka
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

Review 2.  Rubella in the United Kingdom.

Authors:  E Miller
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

3.  Rubella susceptibility and the continuing risk of infection in pregnancy.

Authors:  C L Miller; E Miller; P A Waight
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-16

4.  Incidence of congenital rubella syndrome in 19 regions of Europe in 1980-1986.

Authors:  I De la Mata; P De Wals; H Dolk; M F Lechat; R Beckers; I Borlee; F Lys; R Zori; J Goujard; C Stoll
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

5.  Joint California Department of Health Services-California Medical Association campaign to eliminate congenital rubella syndrome.

Authors:  L Dales; K W Kizer; G V Elliott
Journal:  West J Med       Date:  1988-03

6.  Serological evaluation of a measles, mumps, and rubella vaccine.

Authors:  C M Robertson; V J Bennett; N Jefferson; R T Mayon-White
Journal:  Arch Dis Child       Date:  1988-06       Impact factor: 3.791

7.  Big bang for vaccination.

Authors:  J Badenoch
Journal:  BMJ       Date:  1988-09-24

Review 8.  Rubella vaccination.

Authors:  J Forster
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

9.  Seroepidemiology of rubella in northern Greece.

Authors:  G Gioula; E Diza-Mataftsi; S Alexiou-Daniel; V Kyriazopoulou-Dalaina
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-08       Impact factor: 3.267

10.  Comparison of a whole-virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination.

Authors:  M Zrein; J H Joncas; L Pedneault; L Robillard; R J Dwyer; M Lacroix
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.